Responses to parliamentary questions
Question from Deputy Louis O'Hara - PQ 63875-26
Deputy O'Hara asked about the reimbursement of the cost of GLP-1 drugs for preventative uses. Read the HSE response.
From: Communications and Public Affairs
Published: September 2026
Updated: November 2026
Documents
Summary
To ask the Minister for Health whether her Department is considering reimbursing the cost of GLP-1 drugs for preventative uses such as in cases where a person is pre-diabetic or suffers from other medical conditions such as polyendocrine metabolic ovarian syndrome and a medical professional has advised that the use of these drugs is clinically appropriate.
This is a beta version - your feedback will help us to improve it